AR and prostate cancer: Prostate cancer-associated SPOP mutants (Y87C, Y87N, F102C, S119N, F125V, W131G, F133L, and F133V) fail to bind AR protein, thereby increasing the protein stability and activity of AR during tumorigenesis (96, 100).